Baidu
map

"十三五"时期我国中医药服务能力和可及性显著提升

2021-04-03 田晓航 新华社

记者近日从国家中医药管理局了解到,“十三五”时期,我国中医药服务能力和特色优势进一步彰显,中医药健康服务可及性显著提升。

记者近日从国家中医药管理局了解到,“十三五”时期,我国中医药服务能力和特色优势进一步彰显,中医药健康服务可及性显著提升。

国家中医药管理局数据显示,截至2019年底,中医备案诊所占中医类诊所总数的26.94%;全国85%的二级以上综合医院设置了中医科,多数县级妇幼保健机构能够提供中医药服务;98.3%的社区卫生服务中心、97.1%的乡镇卫生院能提供中医药服务。

中医药服务能力和可及性的提升,得益于服务体系建设日益完善。据了解,“十三五”以来,中央财政累计安排370多亿元,支持全国1000余个中医医院基础设施建设;99家中医医院纳入中医药传承创新工程;780个医疗机构被确定为全国综合医院、专科医院、妇幼保健院中医药工作示范单位。

此外,国家中医药管理局实施基层中医药服务能力提升工程“十三五”行动计划,推动3万多个社区卫生服务中心和乡镇卫生院设置中医综合服务区(中医馆、国医堂),实施基层中医馆健康信息平台建设项目。截至2020年12月底,健康信息平台共接入中医馆1.47万家,平台注册医生3.88万人,平台累计接诊病人1379万人次,有力提升了基层中医药服务能力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-05 cathymary
  6. [GetPortalCommentsPageByObjectIdResponse(id=1986718, encodeId=a4231986e1811, content=<a href='/topic/show?id=a3b9384296e' target=_blank style='color:#2F92EE;'>#可及性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38429, encryptionId=a3b9384296e, topicName=可及性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=754b42, createdName=Luyuxie_9, createdTime=Tue May 04 02:14:34 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968603, encodeId=d92a19686034f, content=<a href='/topic/show?id=9bae21538e3' target=_blank style='color:#2F92EE;'>#中医药服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21538, encryptionId=9bae21538e3, topicName=中医药服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Sun Jan 30 04:14:34 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922827, encodeId=b7f3192282e1c, content=<a href='/topic/show?id=cb6960e4548' target=_blank style='color:#2F92EE;'>#服务能力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60745, encryptionId=cb6960e4548, topicName=服务能力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Jan 07 12:14:34 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907325, encodeId=d075190e32585, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Mon Nov 01 08:14:34 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410121, encodeId=935f141012176, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 05:14:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049805, encodeId=095810498050d, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Sat Apr 03 17:14:34 CST 2021, time=2021-04-03, status=1, ipAttribution=)]
    2021-04-03 运动yd

    中医中药,大多被人诋毁,不过梅斯里总是客观公正的

    0

相关资讯

北京十三五期间深化医药卫生体制改革实施方案发布

据北京日报报道,12月12日从北京市发展改革委获悉,《北京市“十三五”期间深化医药卫生体制改革实施方案》已经发布,到2020年,北京将率先建立比较完善的基本医疗卫生制度,实现发展方式由以治病为中心向以健康为中心转变,进一步提高人民群众的健康水平。

深圳新订14个“小目标” 编制中医药服务网

近日深圳发布《深圳市基层中医院服务能力提升工程“十三五”行动计划实施方案》,提出强化基层中医药服务网络,具体由四部分组成。

中央将投百亿给113所医院

中央遴选百所大医院,由财政掏钱搞升级建设。而遴选结果也终于出炉了,全国各地一共有113家医院入选。

国家自然科学基金委员会关于发布“十三五”第三批重大项目指南及申请注意事项的通告

根据《国家自然科学基金“十三五”发展规划》优先发展领域和委党组关于新时代科学基金战略部署,国家自然科学基金委员会(以下简称自然科学基金委)在深入研讨和广泛征求科学家意见的基础上,研究制定了“十三五”第三批36个重大项目指南(见附件),现予发布。请申请人及依托单位按项目指南中所述的要求和注意事项提出申请。

青海“十三五”医改:人人享有安全、价廉的医疗卫生服务

要努力实现人人享有安全、有效、方便、价廉的医疗卫生服务,基本适应民众多层次的医疗卫生需求。”对于青海省三大“国字号”改革之一的综合医改,8月17日,青海省卫计委体制改革处处长李秀忠如是解读“十三五”期间该省医改工作。

多个省市出台"十三五"护理规划,加薪减负、同工同酬有望实现!

近期,多个省市的地方性十三五护理事业发展规划相继出台,总体来看,增人力、强基层、分层级管理、岗位管理、同岗同薪同待遇、增薪减负等成为规划的关键词。

Baidu
map
Baidu
map
Baidu
map